Terms: = Pancreatic cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
18025 results:
1. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
2. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
[TBL] [Abstract] [Full Text] [Related]
3. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
4. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
[TBL] [Abstract] [Full Text] [Related]
5. Precise planning based on 3D-printed dry-laboratory models can reduce perioperative complications of laparoscopic surgery for complex hepatobiliary diseases: a preoperative cohort study.
Yao WF; Huang XK; Fu TW; Jin L; Du CF; Gao ZY; Wang KD; Dai MG; Liu SY; Liu JW; Zhang CW; Liang L; Huang DS
BMC Surg; 2024 May; 24(1):148. PubMed ID: 38734630
[TBL] [Abstract] [Full Text] [Related]
6. A clinical-radiomics nomogram based on dual-layer spectral detector CT to predict cancer stage in pancreatic ductal adenocarcinoma.
Wu L; Cen C; Yue X; Chen L; Wu H; Yang M; Lu Y; Ma L; Li X; Wu H; Zheng C; Han P
Cancer Imaging; 2024 May; 24(1):55. PubMed ID: 38725034
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
8. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma.
Ozaki M; Kageyama K; Kimura K; Eguchi S; Yamamoto A; Tanaka R; Nota T; Yonezawa H; Nishiofuku H; Sakai Y; Tani N; Jogo A; Terai M; Sato T; Ishizawa T; Miki Y
Sci Rep; 2024 May; 14(1):10529. PubMed ID: 38719893
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
Zhuang J; Wang S; Wang Y; Wu Y; Hu R
BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
11. QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment.
Shinde A; Panchal K; Patra P; Singh S; Enakolla S; Paliwal R; Chaurasiya A
AAPS PharmSciTech; 2024 May; 25(5):97. PubMed ID: 38710894
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiological profile of neuroendocrine tumors in adults in Brazil.
Brunelli Pujatti P; Paim V; Gonçalves R; Vilhena B; Bergmann A; Santos Thuler LC; Bulzico D
Arch Endocrinol Metab; 2024 May; 68():e230013. PubMed ID: 38709149
[TBL] [Abstract] [Full Text] [Related]
13. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
[TBL] [Abstract] [Full Text] [Related]
14. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma.
Akumuo RC; Reddy SP; Westwood C; Devarajan K; Barrak D; Reddy SS; Villano AM
J Gastrointest Surg; 2024 May; 28(5):605-610. PubMed ID: 38704197
[TBL] [Abstract] [Full Text] [Related]
15. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
[TBL] [Abstract] [Full Text] [Related]
16. Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.
Zhan Z; Chen B; Cheng H; Xu S; Huang C; Zhou S; Chen H; Lin X; Lin R; Huang W; Ma X; Fu Y; Chen Z; Zheng H; Shi S; Guo Z; Zhang L
BMC Cancer; 2024 Apr; 24(1):547. PubMed ID: 38689252
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of pancreaticojejunostomy of the pancreatic stump during distal or central pancreatectomy.
Hirashita T; Fujinaga A; Nagasawa Y; Orimoto H; Amano S; Kawamura M; Kawasaki T; Kawano Y; Masuda T; Endo Y; Inomata M
Langenbecks Arch Surg; 2024 Apr; 409(1):145. PubMed ID: 38687358
[TBL] [Abstract] [Full Text] [Related]
18. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
Fu S; Xu Y; Mao Y; He M; Chen Z; Huang S; Li D; Lv Y; Wu J
Cancer Med; 2024 May; 13(9):e7105. PubMed ID: 38686567
[TBL] [Abstract] [Full Text] [Related]
19. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
[TBL] [Abstract] [Full Text] [Related]
[Next]